BEND2 Inhibitors
Inhibitors of BEND2 operate through a myriad of intricate biochemical pathways to achieve a decrease in the functional activity of this protein. For instance, the activity of BEND2 is closely tied to the PI3K/Akt pathway, a critical signaling route for numerous cellular processes. When this pathway is inhibited, BEND2's role in cellular activities is consequently diminished. Similarly, BEND2 relies on the mTOR signaling for its various functions, and allosteric inhibition of mTOR translates into a downstream reduction of BEND2 activity. Modulation of other pathways, such as JAK/STAT, Wnt/β-catenin, and MAPK/ERK, also indirectly impacts BEND2, as these are signaling cascades that BEND2 is directly involved in. The inhibition of JAK/STAT and Wnt/β-catenin pathways leads to a notable decrease in the activity of BEND2, underlining the protein's dependency on these routes for its functional expression.
Moreover, BEND2's activity is subject to regulation by multiple kinase-mediated pathways; for example, Cdk5 phosphorylation is crucial for BEND2's activity, and its inhibition can result in a decreased functional state of BEND2. Inhibition of NF-κB, Hedgehog signaling, and GSK-3β similarly results in a diminished BEND2 activity. These inhibitors work by disrupting the normal signaling mechanisms, thereby indirectly reducing the activity of BEND2. Additionally, modulating cell adhesion pathways through ILK inhibition, and altering kinase activities, such as those of PDK1, play a significant role in the indirect regulation of BEND2.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This compound is a selective inhibitor of mitogen-activated protein kinase kinase (MEK), which in turn is part of the ERK/MAPK pathway. BEND2 activity is related to DNA bending and packaging, which could be influenced by changes in this signaling pathway, leading to its inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of PI3K, LY294002 disrupts the PI3K/AKT signaling pathway. Since BEND2 is implicated in chromatin remodeling and gene expression regulation, the inhibition of this pathway can indirectly lead to reduced BEND2 function by altering the chromatin state. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and inhibits mTOR, a key regulator of protein synthesis and cell growth. By inhibiting mTOR, the compound influences cellular metabolism and growth signals, which can lead to an indirect reduction in BEND2 function as it is involved in these cellular processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A selective inhibitor of ROCK, Y-27632 can alter actin cytoskeleton arrangement. Since BEND2 is related to DNA structure, alterations in cellular architecture would indirectly inhibit BEND2 function by modifying the physical contexts in which BEND2 operates. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
This compound is a selective inhibitor of the TGF-β receptor type I. Alterations in TGF-β signaling can affect the transcriptional regulation of numerous genes, including BEND2, thus leading to indirect inhibition of its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), SP600125 can influence inflammatory signaling pathways. Since BEND2 has been implicated in the regulation of gene expression, the inhibition of JNK signaling may indirectly lower BEND2 activity through changes in gene expression profiles. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor that affects the AKT signaling pathway. By inhibiting AKT signaling, it could indirectly cause a reduction in BEND2 activity given BEND2 is involved in processes regulated by PI3K/AKT, such as cell survival and growth. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylases (HDACs), Trichostatin A alters chromatin structure and gene expression. As BEND2 is involved in DNA bending and associated processes, HDAC inhibition can lead to a change in BEND2's functional landscape and its inhibition. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
By targeting the Hedgehog signaling pathway, Cyclopamine can suppress pathway activation. BEND2, through its role in gene expression regulation, could be indirectly inhibited if it is involved given gene networks regulated by Hedgehog signaling. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
A selective inhibitor of Aurora kinase, ZM-447439 disrupts mitotic spindle formation, potentially affecting cell division. Given BEND2 is involved in cell cycle regulation or operates within dividing cells, its function could be indirectly inhibited by this compound. | ||||||